WO1992012159A1
Expired / Lapsed
WO
⏱️ 0.0 years remaining
Bridged cyclic ketal derivatives
Assignee: Glaxo Group Ltd
•
Filing: 1992-01-05
•
Granted: —
•
Expires: 2012-01-05
Abstract
Abstract Compounds are described of formula (I). These compounds inhibit the enzyme squalene synthase and/or are intermediates for the preparation of compounds which inhibit the enzyme squalene synthase. Compounds of the invention may be formulated for use in a variety of conditions where a lowering of the level of blood plasma cholesterol in animals would be beneficial and for use in combating fungal infections in animals.
Inventors
- 👤 Philip James Sidebottom
- 👤 Michael George Lester
- 👤 Panayiotis Alexandrou Procopiou
- 👤 Nigel Stephen Watson
- 👤 Richard Bell
- 👤 Gerard Martin Paul Giblin
- 👤 Esme Joan BAILEY
- 👤 Barrie Edward Kirk
- 👤 Colin Smith
- 👤 Jan Josef Scicinski
- 👤 Barry Clive Ross
Bibliographic Details
Application Number
—
Jurisdiction
WO
Data Source
google_patents
Last Synchronized
2026-10-23 00:39
CPC Classifications
C; C07; C07D; C07D493/00; C07D493/02; C07D493/08; A; A61; A61P; A61P3/00; A61P3/06; C12; C12P; C12P17/00; C12P17/18; C12P17/181
Claims Analysis
Total Claims: 0
No claims parsed yet. Click Sync Now above to re-index claims from Google Patents.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.